Cargando…

Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016–2018

BACKGROUND: Bone metastases cause significant morbidity in patients with cancer, and radiation therapy (RT) is an effective treatment approach. Indications for more complex ablative techniques are emerging. We sought to evaluate RT trends at a large multi-site tertiary cancer center. METHODS: Patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gillespie, Erin F., Lapen, Kaitlyn, Wang, Diana G., Wijetunga, N., Pastrana, Gerri L., Kollmeier, Marisa A., Yamada, Josh, Schmitt, Adam M., Higginson, Daniel S., Vaynrub, Max, Santos Martin, Ernesto, Xu, Amy J., Tsai, C., Yerramilli, Divya, Cahlon, Oren, Yang, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575833/ https://www.ncbi.nlm.nih.gov/pubmed/33102818 http://dx.doi.org/10.1016/j.ctro.2020.10.001

Ejemplares similares

Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis
por: Shin, Jacob Y., et al.
Publicado: (2022)

Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery
por: Freret, Morgan E., et al.
Publicado: (2022)

Multidisciplinary Treatment of Non-Spine Bone Metastases: Results of a Modified Delphi Consensus Process
por: Gillespie, Erin F., et al.
Publicado: (2022)

30 GY IN 4 STEREOTACTIC BODY RADIOTHERAPY (SBRT) FRACTIONS FOR COMPLEX SPINAL METASTASES: MATURE OUTCOMES SUPPORTING THIS NOVEL REGIMEN
por: Moore-Palhares, Daniel, et al.
Publicado: (2023)

Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017
por: Santos, Patricia Mae G., et al.
Publicado: (2022)

Patterns of Recurrence Among Higher-Risk Patients Receiving Daily External Beam Accelerated Partial-Breast Irradiation to 40 Gy in 10 Fractions
por: Fitzgerald, Kelly, et al.
Publicado: (2019)

12 × 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma?
por: Lubgan, Dorota, et al.
Publicado: (2021)

Failure mode and effect analysis for linear accelerator‐based paraspinal stereotactic body radiotherapy
por: Lee, Sangkyu, et al.
Publicado: (2021)

Stereotactic Radiosurgery for Vestibular Schwannomas: Reducing Toxicity With 11 Gy as the Marginal Prescribed Dose
por: Dupic, Guillaume, et al.
Publicado: (2020)

Should Postoperative Radiation for Long Bone Metastases Cover Part or All of the Orthopedic Hardware? Results of a Large Retrospective Analysis
por: Rosen, Daniel B., et al.
Publicado: (2021)

Case report: Stereotactic body radiation therapy with 12 Gy for silencing refractory ventricular tachycardia
por: Huang, Shan-Hui, et al.
Publicado: (2022)

Prospective Clinical Evaluation of Integrating a Radiation Anatomist for Contouring in Routine Radiation Treatment Planning
por: Zhang, Helen, et al.
Publicado: (2022)

Flattening filter free VMAT for a stereotactic, single‐dose of 30 Gy to lung lesion in a 15‐min treatment slot
por: Pokhrel, Damodar, et al.
Publicado: (2020)

Randomized Pilot Study of 20 Gy in 5 Fractions versus 27 Gy in 3 Fractions Radiotherapy for Treating Painful Bone Metastases: A Single Institution Experience
por: Sakr, Amr, et al.
Publicado: (2020)

Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study
por: Aoki, Shuri, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer
por: Yang, Dan, et al.
Publicado: (2020)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

A retrospective study of sinonasal tumors in 182 dogs treated with stereotactic radiotherapy (3 × 10 Gy) (2010‐2015)
por: Yoshikawa, Hiroto, et al.
Publicado: (2023)

Damage to the Superior Retinae After 30 Gy Whole-Brain Radiation
por: Chan, Lawrence, et al.
Publicado: (2021)

Biologically effective doses of 60–70Gy versus >70Gy of stereotactic body radiotherapy (SBRT) combined with chemotherapy in locally advanced pancreatic cancer: protocol of a single-centre, phase II clinical trial
por: Ye, Yusheng, et al.
Publicado: (2022)

Outcomes of stereotactic body radiotherapy 60 Gy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors
por: Zhao, Yizhou, et al.
Publicado: (2020)

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
por: Kim, Yeon Joo, et al.
Publicado: (2018)

Preoperative Stereotactic Radiosurgery for Brain Metastases
por: Routman, David M., et al.
Publicado: (2018)

Draft Genome Sequences of Dysgonomonas sp. Strains GY75 and GY617, Isolated from the Hindgut of Reticulitermes flavipes
por: Bridges, Charles M., et al.
Publicado: (2021)

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Efficacy of 8 Gy Single Fraction Palliative Radiation Therapy in Painful Bone Metastases: A Single Institution Experience
por: Shuja, Muhammad, et al.
Publicado: (2018)

Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
por: Dubaere, Emilie, et al.
Publicado: (2019)

Stereotactic Radiosurgery and Ipilimumab Versus Stereotactic Radiosurgery Alone in Melanoma Brain Metastases
por: Nguyen, Steven M, et al.
Publicado: (2017)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Elective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity
por: Murthy, Vedang, et al.
Publicado: (2017)

Kidney Cell DNA Damage Caused By Combined Exposure To Volatile Anaesthetics and 1 Gy Or 2 Gy Radiotherapy Dose in Vivo
por: Benković, Vesna, et al.
Publicado: (2022)

EXTERNAL BEAM RADIOTHERAPY FOR PAINFUL BONE METASTASES FROM HEPATOCELLULAR CARCINOMA: MULTIPLE FRACTIONS COMPARED WITH AN 8-GY SINGLE FRACTION
por: HAYASHI, SHINYA, et al.
Publicado: (2014)

Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalent to 2 Gy per fraction((α/β=3Gy)) at 2 cm(3) of vagina
por: Aguilera, María del Valle, et al.
Publicado: (2018)

The Usefulness of Stereotactic Radiosurgery for Radioresistant Brain Metastases
por: Kim, Hyool, et al.
Publicado: (2013)

Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases
por: Marchan, Eduardo M., et al.
Publicado: (2018)

Stereotactic Radiosurgery as Treatment for Brain Metastases: An Update
por: Peña-Pino, Isabela, et al.
Publicado: (2023)

Long‐term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer
por: Wijetunga, N. Ari, et al.
Publicado: (2021)

Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer
por: Han, Dan, et al.
Publicado: (2015)

Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity
por: Jolnerovski, Maria, et al.
Publicado: (2017)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1jutldru6diq78vcjtqeiiuq4e